Med2x
Med2x is a Private Indian company incorporated in 2008 and based in Gujarat, India. Med2x operates in IT & Software (NIC 72200) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Med2x - Cloud-based platform providing hospital and labaratory administrative management solutions. Public Company.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Med2x.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Med2x.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 383134241 | Axis Bank Ltd(Bank) | ₹16.32 Cr | 04 Jul 2020 | Open |
| 571043462 | Kotak Mahindra Bank Ltd(Bank) | ₹22.34 Cr | 27 Jan 2023 | Open |
| 931320056 | State Bank of India(Bank) | ₹22.31 Cr | 12 Mar 2021 | Open |
| 965511150 | ICICI Bank Ltd(Bank) | ₹8.91 Cr | 04 Jul 2021 | Open |
| 591275027 | HDFC Bank Ltd(Bank) | ₹7.73 Cr | 19 Sep 2021 | Satisfied |
| 918630929 | Kotak Mahindra Bank Ltd(Bank) | ₹2.83 Cr | 04 Jul 2020 | Open |
Charge IDs, lenders & amounts for Med2x.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹39.76 Cr | ₹-35.07 L | ₹29.21 Cr | ₹56.54 Cr | 418 |
| FY2023-24 | ₹35.05 Cr | ₹-7.13 L | ₹16.71 Cr | ₹38.28 Cr | 214 |
| FY2022-23 | ₹25.52 Cr | ₹-60.79 L | ₹12.87 Cr | ₹27.88 Cr | 81 |
| FY2021-22 | ₹24.97 Cr | ₹-9.08 L | ₹20.37 Cr | ₹38.40 Cr | 242 |
Audited financials & ratios for Med2x.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹39.76 Cr | ₹35.05 Cr | ₹25.52 Cr | ₹24.97 Cr |
| Other income | ₹1.18 Cr | ₹21.62 L | ₹72.07 L | ₹52.11 L |
| Total income | ₹40.94 Cr | ₹35.27 Cr | ₹26.24 Cr | ₹25.49 Cr |
| Total expenses | ₹41.39 Cr | ₹35.36 Cr | ₹27.02 Cr | ₹25.61 Cr |
| Profit before tax | ₹-45.59 L | ₹-9.27 L | ₹-79.03 L | ₹-11.80 L |
| Profit / (Loss) after tax | ₹-35.07 L | ₹-7.13 L | ₹-60.79 L | ₹-9.08 L |
| Balance sheet | ||||
| Equity / Net worth | ₹29.21 Cr | ₹16.71 Cr | ₹12.87 Cr | ₹20.37 Cr |
| Borrowings | ₹6.37 Cr | ₹8.82 Cr | ₹8.11 Cr | ₹8.88 Cr |
| Current liabilities | ₹11.27 Cr | ₹11.45 Cr | ₹7.22 Cr | ₹7.89 Cr |
| Total liabilities | ₹27.33 Cr | ₹21.57 Cr | ₹15.02 Cr | ₹18.03 Cr |
| Current assets | ₹20.75 Cr | ₹21.83 Cr | ₹15.49 Cr | ₹19.00 Cr |
| Cash & equivalents | ₹5.03 Cr | ₹7.84 Cr | ₹3.03 Cr | ₹4.55 Cr |
| Total assets | ₹56.54 Cr | ₹38.28 Cr | ₹27.88 Cr | ₹38.40 Cr |
| Employees | 418 | 214 | 81 | 242 |
Audited financials & ratios for Med2x.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹39.76 Cr | +17.9% | +4.9% | +6.7% |
| Profit after Tax | ₹-35.07 L | +33.2% | +13.6% | -1.0% |
| Net Worth | ₹29.21 Cr | +31.3% | +8.1% | +3.6% |
| Employees | 418 | -5.4% | +0.3% | +11.3% |
Audited financials & ratios for Med2x.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹39.76 Cr | ₹-35.07 L | -0.88% | +3.54% | -1.20% | -0.62% | 0.22 | ₹9.51 L |
| FY2023-24 | ₹35.05 Cr | ₹-7.13 L | -0.20% | +25.77% | -0.43% | -0.19% | 0.53 | ₹16.38 L |
| FY2022-23 | ₹25.52 Cr | ₹-60.79 L | -2.38% | +37.73% | -4.72% | -2.18% | 0.63 | ₹31.50 L |
| FY2021-22 | ₹24.97 Cr | ₹-9.08 L | -0.36% | +16.63% | -0.45% | -0.24% | 0.44 | ₹10.32 L |
Audited financials & ratios for Med2x.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 53,31,310 | 88.48% |
| Institutional Investors | 3 | 1,61,538 | 2.68% |
| Public & Others | 36 | 5,32,342 | 8.84% |
Promoter, institutional & public holding for Med2x.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
26 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.